We found that various ceramides were elevated in NASH liver tissues (Fig. 1h) and that Acer3 deficiency specifically augmented the increase of C18:1-ceramide but not other ceramide species, SPH, or sphingosine-1-phosphate (S1P) (Fig. 1h, i). Here, ACER3 is linked to metabolic dysfunction-associated steatohepatitis.